RARE DISEASERESEARCH ATLAS

ORPHA:2316

Johnson neuroectodermal syndrome

high confidence

Also known as: Alopecia-anosmia-conductive hearing loss-hypogonadism syndrome · Alopecia-anosmia-deafness-hypogonadism syndrome · Johnson-McMillin syndrome

Query health: suspect — Only one of 2 strategies returned hits (phrase).

Clinical definition (Orphanet)

A rare neuroectodermal syndrome characterized by hypotrichosis/alopecia, hyposmia/anosmia, conductive deafness associated with protruding ears, microtia, and/or atresia of the external auditory canal, hypogonadotropic hypogonadism, and a greater than normal tendency to dental caries. Some patients may also present with mild facial asymmetry, cleft palate, facial nerve palsy, heart defect, multiple truncal café-au-lait spots, and /intellectual deficiency.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Is anyone studying this?

18

18 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=183) is 38.

18 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 38 (publications denominator n=183).

5 in the last 10 years · high confidence · 22.4th percentile (publications denominator)

Is a treatment being tested?

0

trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 26 July 2026

No matched interventional trials. This is true for 59.2% of diseases in the trials denominator (151 of 255). Here are the researchers publishing on it.

high confidence · 29.6th percentile (trials denominator)

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Who's working on it?

123

Distinct author names in 18 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Guion-Almeida ML2 papers · 2015

    Department of Clinical Genetics, Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo, Bauru 17012-900, Brazil.

    Papers in Europe PMC
  2. 02
    Weaver DD2 papers · 2015

    Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

    Papers in Europe PMC
  3. 03
    Zechi-Ceide RM2 papers · 2015

    Department of Clinical Genetics, Hospital for Rehabilitation of Craniofacial Anomalies, University of São Paulo, Bauru 17012-900, Brazil.

    Papers in Europe PMC
  4. 04
    Abdel-Meguid N1 paper · 2014

    Department of Children with Special Needs, Medical Division, National Research Centre, Cairo, Egypt.

    Papers in Europe PMC
  5. 05
    Abdelraouf ER1 paper · 2014

    Department of Children with Special Needs, Medical Division, National Research Centre, Cairo, Egypt.

    Papers in Europe PMC
  6. 06
    Adameyko I1 paper · 2015

    Unit of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm 17177, Sweden.

    Papers in Europe PMC
  7. 07
    Adir N1 paper · 2008
    Papers in Europe PMC
  8. 08
    Amiel J1 paper · 2015

    INSERM UMR 1163, Institut Imagine, Paris 75015, France; Université Paris Descartes-Sorbonne Paris Cité, Institut Imagine, Paris 75015, France; Service de Génétique, Hôpital Necker-Enfants Malades, AP-HP, Paris 75015, France. Electronic address: jeanne.amiel@inserm.fr.

    Papers in Europe PMC
  9. 09
    Bahgat M1 paper · 2014

    Department of Ear Nose and Throat, Faculty of Medicine, Cairo University, Cairo, Egypt.

    Papers in Europe PMC
  10. 10
    Bankier A1 paper · 1994
    Papers in Europe PMC

Recruiting interventional trials

Trials testing a treatment from the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it above — people publishing on this disease are often the practical next contact when no trial is listed.

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored below but are not added to the query string.

"Johnson neuroectodermal syndrome" OR "Alopecia-anosmia-conductive hearing loss-hypogonadism syndrome" OR "Alopecia-anosmia-deafness-hypogonadism syndrome" OR "Johnson-McMillin syndrome"

Run this search on Europe PMC

MeSH descriptor terms unioned into the query: Johnson neuroectodermal syndrome

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Johnson neuroectodermal syndrome" OR "Alopecia-anosmia-conductive hearing loss-hypogonadism syndrome" OR "Alopecia-anosmia-deafness-hypogonadism syndrome" OR "Johnson-McMillin syndrome"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Cross-references (from Mondo): MESH:C535882 OMIM:147770 UMLS:C0796002

Query health: suspect — strategies attempted: phrase, mesh; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Report an error for ORPHA:2316